Literature DB >> 15721834

Mechanisms of mycobacterial persistence in tuberculosis.

David J Kusner1.   

Abstract

Tuberculosis is one of the world's most devastating diseases, with more than two million deaths and eight million new cases occurring annually. Mycobacterium tuberculosis evades the innate antimicrobial defenses of macrophages by inhibiting the maturation of its phagosome to a bactericidal phagolysosome. Phagosome maturation is dependent on macrophage Ca(2+) signaling, which results in the recruitment of cytosolic calmodulin (CaM) to the phagosome membrane and subsequent focal activation of CaM kinase II (CaMKII). M. tuberculosis blocks this process via inhibition of a macrophage enzyme, sphingosine kinase, which is a proximal generator of Ca(2+) signaling during phagocytosis. This results in a failure of assembly of the Ca(2+)/CaM/CaMKII signaling complex on the membrane of the mycobacterial phagosome and the bacilli's persistence and replication in a protective intracellular niche. Pharmacologic or physiologic reversal of this inhibition of macrophage Ca(2+) signaling restores the normal sequence of phagosome maturation, resulting in decreased intracellular viability of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721834     DOI: 10.1016/j.clim.2004.07.016

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  32 in total

Review 1.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens.

Authors:  S F Connolly; D J Kusner
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  Mycobacteria and innate cells: critical encounter for immunogenicity.

Authors:  Angelo Martino
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

4.  Importance of phagosomal functionality for growth restriction of Mycobacterium tuberculosis in primary human macrophages.

Authors:  Amanda Welin; Johanna Raffetseder; Daniel Eklund; Olle Stendahl; Maria Lerm
Journal:  J Innate Immun       Date:  2011-05-11       Impact factor: 7.349

Review 5.  Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines.

Authors:  Raymonde B Bekale; Su-Mari Du Plessis; Nai-Jen Hsu; Jyoti R Sharma; Samantha L Sampson; Muazzam Jacobs; Mervin Meyer; Gene D Morse; Admire Dube
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

6.  Biochemical and microbiological evaluation of N-aryl urea derivatives against mycobacteria and mycobacterial hydrolases.

Authors:  Abhishek Vartak; Christopher Goins; Vinicius Calado Nogueira de Moura; Celine M Schreidah; Alexander D Landgraf; Boren Lin; Jianyang Du; Mary Jackson; Donald R Ronning; Steven J Sucheck
Journal:  Medchemcomm       Date:  2019-06-04       Impact factor: 3.597

7.  Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages.

Authors:  Hridayesh Prakash; Anja Lüth; Natalia Grinkina; Daniela Holzer; Raj Wadgaonkar; Alexis Perez Gonzalez; Elsa Anes; Burkhard Kleuser
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

8.  Induction of ER stress in macrophages of tuberculosis granulomas.

Authors:  Tracie A Seimon; Mi-Jeong Kim; Antje Blumenthal; Jovanka Koo; Sabine Ehrt; Helen Wainwright; Linda-Gail Bekker; Gilla Kaplan; Carl Nathan; Ira Tabas; David G Russell
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

9.  In vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection.

Authors:  Pantelis Constantoulakis; Eftihia Filiou; Nikoletta Rovina; George Chras; Aggeliki Hamhougia; Simona Karabela; Adamandia Sotiriou; Charis Roussos; Nikolaos Poulakis
Journal:  BMC Infect Dis       Date:  2010-08-18       Impact factor: 3.090

10.  Mycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatin.

Authors:  Sarah K Parker; Robert M Barkley; John G Rino; Michael L Vasil
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.